Alethea Cope - Concepedia

Concepedia

Author

Alethea Cope

University College London ORCID

Also Known As

A Cope, A. Cope, A. V. Cope, A.V. Cope, A. V. Cope, Alethea Cope, Alethea V Cope, Alethea V. Cope, Cope, Alethea

39

Publications

2.4K

Citations

23

H-Index

33

Concepts

All Affiliations

University College London Imperial College London The Royal Free Hospital St George's, University of London MRC Clinical Trials Unit at UCL

AC

About

Alethea Cope is an author at University College London specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.1K
2	Immunology	11	11	1.1K
3	Allergy	3	3	179
4	Epidemiology	2	2	133
5	Hepatology	1	1	154

Alethea Cope

×

28

Publications

2.4K

Citations

22

H-Index

	Year	Citations
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation Vincent C. Emery, Caroline Sabin, Alethea Cope, The Lancet Diagnostic VirologyTransplantationViral PersistenceCytomegalovirus DiseaseImmunology	2000	548
The Dynamics of Human Cytomegalovirus Replication in Vivo Vincent C. Emery, Alethea Cope, E Frances Bowen, The Journal of Experimental Medicine	1999	256
Interrelationships among Quantity of Human Cytomegalovirus (HCMV) DNA in Blood, Donor‐Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for HCMV Disease following Liver Transplantation Alethea Cope, Caroline Sabin, Andrew K. Burroughs, The Journal of Infectious Diseases	1997	201
Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus Paul Griffiths, Mounir Ait‐Khaled, C P Bearcroft, Journal of Medical Virology Viral DiagnosticsImmunologyPathologyHuman HerpesvirusesViral Persistence	1999	154
Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel Martin Cranage, Sally Sharpe, Carolina Herrera, PLoS Medicine	2008	151
Prospective Study of the Effects of Antiretroviral Therapy on Kaposi Sarcoma–Associated Herpesvirus Infection in Patients With and Without Kaposi Sarcoma Jasjit Gill, Dimitra Bourboulia, John Wilkinson, JAIDS Journal of Acquired Immune Deficiency Syndromes	2002	120
Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre Victoria Gould, James N. Francis, Katie Anderson, Frontiers in Microbiology VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentHuman Influenza Challenge	2017	115
Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival Frances Bowen, Pauline Wilson, Alethea Cope, AIDS	1996	113
Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy John Wilkinson, Alethea Cope, Jas Gill, Journal of Virology ImmunologyKshv-specific ResponsesPathologyImmune RestorationCd4 T Cell Responses	2002	103
Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation Alethea Cope, P. Sweny, Caroline Sabin, Journal of Medical Virology	1997	91

Page 1